Apps

US finalizes up to 249% duties on Indian solar cells — 6dThe United States has finalized steep anti-dumping and countervailing duties on solar cells and panels from India, Indonesia and Laos, with India facing AD 123.04% and CVD 126.09% (Indonesia and Laos rates vary up to 173.7% and 153.67% respectively). The USITC will issue a final injury determination on October 14, 2026; if it finds injury, duties would be formally ordered by early November, impacting Indian exporters and potentially prompting shifts to other markets as the investigation concludes.

Elena Vasquez Protecting local industry makes sense, but 249% duties seem extreme and could slow overall clean energy growth.

Volvo Plans One of Sweden’s Largest Energy Parks — Sep 10, 2026Volvo Group plans one of Sweden's largest energy parks in Mariestad beside its planned battery cell factory, starting with about 70 MW/260 MWh of storage to support the regional grid and enable a future test bed for energy innovations, with commissioning targeted for 2027. The park will operate in two tracks and is designed to grow alongside the battery cell plant expected after 2030, reinforcing Volvo's regional industrial cluster and decarbonization efforts.

Priya Raman This storage addition makes sense to back up the grid while the battery plant scales up later.

Cellectis Exits Two CAR-T Programs, Advances Gene Editing — 4dCellectis announced a strategic transformation to become an in vivo gene editing company, shifting resources to two lead programs HEAL-101 and HEAL-201 for severe dyslipidemias and exiting lasme-cel and eti-cel to extend its cash runway into the second half of 2028, while realigning its operating model around the in vivo pipeline. Phase 1 data are planned for HEAL-101 in the second half of 2027 and for HEAL-201 in the first half of 2028, with ongoing cell therapy partnerships and a September 14 conference call to discuss updates.

Dana Whitfield Exiting the CAR-T candidates to reach 2028 cash runway is understandable but leaves them with pretty distant phase 1 readouts.

Roche seals $1.53B Simcere trispecific deal — Sep 1, 2026Roche agreed to pay $75 million upfront to acquire exclusive global rights to SIM0660, a preclinical trispecific antibody from Simcere Zaiming that targets CD79a, CD19 and CD3, with total potential payments up to $1.53 billion and tiered royalties up to double digits. The therapy is designed to trigger T-cell–mediated killing across B-cell–mediated diseases, including autoimmune conditions, highlighting a growing collaboration between Roche and a Chinese biotech.

Maya Lindstrom Chinese biotech deals with big pharma keep growing, Simcere Zaiming landing this shows their pipeline is getting real attention.

BMW iX5 Hydrogen Prototypes Test 466-Mile Range Ahead of Production — 4dBMW’s iX5 Hydrogen is advancing toward its first hydrogen-powered series production with extensive real-world and prototype testing; the third-generation fuel-cell system (co-developed with Toyota) is in a new assembly phase in Munich while Steyr prepares for production, as engineers validate the integrated drivetrain, high-voltage system, and storage to meet targets of up to 750 km range, sub‑5-minute refuelling, and 0-100 km/h in under 5 seconds. The program emphasizes coordinated system performance under high loads and knowledge transfer to Steyr for manufacturing, signaling BMW’s push to add a hydrogen option alongside its existing powertrains.

Bristol Myers exits Cellares deal, capacity doubt — Aug 25, 2026Bristol Myers Squibb has ended its partnership with cell therapy manufacturer Cellares, raising questions about standardized production capacity for CAR‑T and forcing a reevaluation of forecasting and capacity planning. In the wake of the deal termination, Cellares is restructuring and cutting jobs as it absorbs the loss of a major customer, underscoring fragility in automated cell therapy manufacturing ecosystems.

China reportedly pauses approvals for new battery storage factories amid overcapacity concerns — Sep 7, 2026China paused approvals for new battery storage factory projects not yet under construction and launched a review of existing and planned capacity to curb chronic overcapacity in energy-transition sectors, continuing a broader crackdown after actions in EVs and solar panels. The government also announced export taxes on various batteries and photovoltaic cells starting in 2026–2028, while exempting new-technology batteries until December 2028.

Chris Dalton Curious how this affects battery prices globally if China actually reins in production instead of just talking about it.

Two Contra Costa County Shootings Injure OfficersWorld — Sep 4, 2026A 31-year-old suspect at the Pittsburg Police Department allegedly was not properly searched before being placed in a holding cell, and during the exchange of the officer later, a gun was fired injuring the officer and the suspect. Authorities say the officer is in serious but stable condition and the suspect is in stable condition, with multiple outlets updating the developing story as investigations continue.

How Likely Is An Iranian Sleeper Cell Attack On US Soil? — Jun 24, 2025The U.S. strike against Iran on Saturday night has ignited fears that Iran may choose to orchestrate attacks against Americans with undercover agents. Iran threatened to activate sleeper cells in the U.S. days before…

New Cartel Cell Encroaching on Mexican Border City — Jun 24, 2025A cell of gunmen believed to be tied either to Cartel Jalisco New Generation or Carteles Unidos has been trying to set up their operation in the border city of Piedras Negras, Coahuila, just south of Eagle Pass. By the…

Harvey Weinstein’s Lawyer Not Happy With Client’s Holding Cell: ‘Almost Medieval’Reporting — Oct 12, 2022Harvey Weinstein’s lawyer is disturbed by the conditions of his client’s holding cell. The New York Post reported Attorney Mark Werksman made the comments about the conditions in his pleas to a judge Tuesday. “It’s…

President Trump Acknowledges Iranian Sleeper Cells In US — Mar 13, 2026President Donald Trump warned Wednesday that potential terrorist “sleeper cells” could already be inside the United States, suggesting many may have entered during former President Joe Biden’s border policies. Speaking…

National Security Expert Warns Risk of Sleeper Cells in US — Mar 2, 2026A national security expert is stating there may be danger close to home as sleeper cell activity within the United States poses increasing danger. To that end, former Department of Homeland Security (DHS) advisor…

Chinese Hackers Reportedly Breached Cell Phones Of Trump, Vance — Oct 25, 2024Chinese hackers targeted the cell phones of former President Donald Trump and his running mate J.D. Vance, according to The New York Times. The Trump campaign was notified at some time earlier this week that Trump and…

5-Year-Old Boy Cured of Sickle Cell AnemiaReporting — Oct 24, 2023A 5-year-old boy has been miraculously cured of sickle cell anemia , which is being hailed as a “medical breakthrough.” According to CBS News , New Jersey boy Tobi Okunseinde was diagnosed with the disease before his…

Antifa Terror Cell Leader Sent To Slammer For Rest Of His Life In Landmark Sentencing — Jun 23, 2026Antifa cell leader Benjamin Song was sentenced to 100 years in prison Tuesday for a 2025 terrorist attack on an immigration facility. The Department of Justice (DOJ) sentenced Song and seven others involved in the July…

Cancer Survivor Meets Stem Cell Donor Who Saved Her LifeReporting — Sep 25, 2024From left: Alison Belsham with her donor, Rachel Rees. WELSH BLOOD SERVICE VIA SWNS. “> A cancer survivor set up a surprise meeting – with the stem cell donor who saved her life. Alison Belsham, 57, and donor Rachel…

Vatican Green Lights Receiving COVID-19 Vaccines That Used Abortion Cell Lines: ‘Morally Acceptable’Reporting — Dec 22, 2020The Vatican is giving the go-ahead on receiving COVID-19 vaccines that used cell lines from aborted fetuses. The Vatican’s Congregation for the Doctrine of the Faith wrote in a statement published on Monday, “It is…

Michael Avenatti Is Using the Same Jail Cell That Once Held ‘El Chapo,’ Lawyer SaysReporting — Jan 21, 2020Attorney Michael Avenatti could be using the same jail cell that once housed convicted Mexican drug lord Joaquin “El Chapo” Guzman , his lawyer says. Scott Srebnick, attorney for Avenatti, wrote a letter on Monday to…

DOJ Includes Clip Of Disputed Epstein Jail Cell Footage In Files — But Quickly Kills Link — Dec 23, 2025Several prominent social-media influencers on Monday circulated a video — claiming it came from the Department of Justice — that shows Jeffrey Epstein attempting to take his own life inside a jail cell. The short clip…

‘Alarming Mental Health Crisis’: Red State Gov Cracks Down On Cell Phones In Classrooms With Executive OrderReporting — Jul 9, 2024Republican Gov. Glenn Youngkin issued an executive order on Tuesday to establish cell phone-free education for Virginia’s K-12 public schools. Youngkin issued Executive Order 33 , which directs the Virginia Department…

Creative Biolabs Expands Complement, Cell Therapy ResearchHealth — Jul 24, 2026Creative Biolabs is expanding advanced research services in complement therapeutics, iPSC characterization, and macrophage assays to meet the rising needs of precision medicine, immunotherapy, and regenerative medicine. The company positions itself as a key partner for validating complex cell-based therapies and understanding immune pathway interactions to support robust preclinical data.

Flaking Process Revolutionizes Soybean Oil ExtractionScience — Jul 24, 2026The articles describe soybean flaking as pressing crushed soybeans between two counter-rotating rolls to produce thin flakes, which rupture cell walls, increase surface area, and shorten the oil diffusion path to speed extraction. They explain that when rolls run at the same speed, compression dominates, but differing speeds induce kneading and shearing that further disrupt cells and improve oil extraction by expanding contact with the solvent.

Zydus Lifesciences plans Phase III Desidustat trial sickle cell ICMR — Jul 23, 2026Zydus Lifesciences has received regulatory approval to initiate a 203-day Phase III trial of Desidustat for sickle cell disease in collaboration with ICMR, enrolling 164 patients to assess efficacy and safety of the oral tablet. The move follows successful Phase II results and US FDA Orphan Drug Designation, underscoring a public-private effort to address India's substantial SCD burden.

Discussions